BioStem Technologies, Inc. (BSEM) vs Werewolf Therapeutics, Inc. (HOWL)
A side-by-side comparison of BioStem Technologies, Inc. and Werewolf Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.69HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — BSEM vs HOWL
growth of $100 · dividends reinvested · last 5yBSEM +84.0% (+13.0%/yr)HOWL -94.2% (-43.5%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM HOWL
BSEM vs HOWL: by the numbers
- •BSEM is the larger company ($46M vs $45M market cap).
- •Both run net losses; BSEM's is the smaller (-13.86% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | BSEM | HOWL |
|---|---|---|
| P/S ratio | N/A | 2.15 |
| P/B ratio | 1.65 | 2.77 |
Profitability
| Metric | BSEM | HOWL |
|---|---|---|
| Gross margin | 93.13% | 0.00% |
| Operating margin | -1.45% | 0.00% |
| Net margin | -13.86% | -164.82% |
| ROE | -102.45% | -212.45% |
| ROIC | -80.92% | -156.97% |
Growth (annualized)
| Metric | BSEM | HOWL |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | -44.27% |
Frequently asked
- How have BSEM and HOWL total returns compared?
- Over the past 5 years, BSEM delivered 15.72% and HOWL delivered -44.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.